ASH1L | Ash1 (absent, small, or homeotic)-like (Drosophila) | Enzymes
| | | | | Expressed in all |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ATAD2 | ATPase family, AAA domain containing 2 | Enzymes
| | | | | Mixed |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Transporters
| | | | | Expressed in all |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B4GALT3 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 | Enzymes
| | | | | Expressed in all |
BAZ1B | Bromodomain adjacent to zinc finger domain, 1B | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
BCKDK | Branched chain ketoacid dehydrogenase kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins
| | | | | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | | | Group enriched |
BLMH | Bleomycin hydrolase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BPGM | 2,3-bisphosphoglycerate mutase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA5B | Carbonic anhydrase VB, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2, beta | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CCBL1 | Cysteine conjugate-beta lyase, cytoplasmic | Enzymes
| | | | | Expressed in all |
CDC14A | Cell division cycle 14A | Enzymes Plasma proteins
| | | | | Mixed |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK11A | Cyclin-dependent kinase 11A | Enzymes
| | | | | Expressed in all |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CDK16 | Cyclin-dependent kinase 16 | Enzymes
| | | | | Expressed in all |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins
| | | | | Mixed |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CDK9 | Cyclin-dependent kinase 9 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CDYL | Chromodomain protein, Y-like | Enzymes
| | | | | Expressed in all |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |